Is Your 'Focus Supplement' a Warning Sign? High Tyrosine Levels Linked to Shorter Lifespan in Men
Tyrosine, an amino acid widely marketed as a cognitive enhancer to sharpen focus, may be linked to a significant reduction in male longevity.
Search results for "Bio"
Hanmi’s 'Amoprel' Makes Global Waves: World’s First Ultra-Low Triple Hypertension Drug Lands in JACC
The Phase 3 clinical trial results for Hanmi Pharmaceutical’s Amoprel—the world’s first ultra-low-dose triple antihypertensive drug—were published on...
VigenCell "Primary Endpoint Achieved"... Will a Domestic NK/T Lymphoma New Drug Be Born?
VigenCell has announced plans to apply for conditional approval within the year as it successfully completed...
"Is Waking Up at 5 AM the Key to Success?": The Uncomfortable Truth About Early Rising
At 5 AM, while darkness still lingers, a subset of the population is already turning off alarms to exercise, journal,...
The Electric Bond: How Mussel-Inspired Adhesives are Restoring Severed Nerves
Whether it is a victim of a car accident with severed peripheral nerves, an athlete with a torn muscle, or a patient...
The "Mini Jet Lag" of Spring: Why Your Body Struggles with Seasonal Transitions
If your body feels unusually heavy and unrefreshed despite getting enough sleep lately, the culprit may not be your...
Onconic’s ‘Nesuparib’ Secures U.S. FDA Orphan Drug Designation for Small Cell Lung Cancer
Onconic Therapeutics announced on the 24th that its novel anti-cancer candidate, 'Nesuparib', has been designated as an...
U.S. and EU Escalate Pressure on China: A Turning Point for K-Bio?
As the United States prepares to announce the initial regulatory targets of the Biosecurity Act this week, market...
K-Bio Targets Global Expansion: HK inno.N and HLB Seek FDA Approval
South Korean pharmaceutical and biotech companies are aggressively pursuing product approvals and clinical trials with...
Samsung Bioepis Set to Launch Eylea Biosimilar in the U.S. Next January
Samsung Bioepis announced on the 12th that it has entered into a patent license agreement with the original developer...